Table 2

sCD30 concentration in cases and controls

sCD30 concentration, ng/mLCases (N = 234)Controls (N = 234)P*
All subjects 18.8 (11.3-29.7) 13.5 (8.8-20.6) < .001 
By number of years from blood draw to case diagnosis    
    1-2 (N = 62 matched pairs) 18.3 (10.8-29.0) 13.0 (8.9-20.2) < .001 
    3-5 (N = 79) 18.1 (11.9-33.9) 14.4 (8.4-19.8) < .001 
    6-10 (N = 93) 19.8 (10.9-28.3) 12.9 (9.2-21.3) < .001 
sCD30 concentration, ng/mLCases (N = 234)Controls (N = 234)P*
All subjects 18.8 (11.3-29.7) 13.5 (8.8-20.6) < .001 
By number of years from blood draw to case diagnosis    
    1-2 (N = 62 matched pairs) 18.3 (10.8-29.0) 13.0 (8.9-20.2) < .001 
    3-5 (N = 79) 18.1 (11.9-33.9) 14.4 (8.4-19.8) < .001 
    6-10 (N = 93) 19.8 (10.9-28.3) 12.9 (9.2-21.3) < .001 

Median (interquartile range).

*

P value from Wilcoxon signed-rank test of sCD30 distribution in case-control pairs.

Close Modal

or Create an Account

Close Modal
Close Modal